Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 20:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- MX$95.55T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | MX$90B | MX$256.37 | 2.16% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | MX$180.6B | MX$1,901.77 | 7.46% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | MX$122.5B | MX$1,806.12 | 0.60% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | MX$99.5B | MX$2,357.83 | 0.52% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | MX$74.3B | MX$542.55 | 2.11% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | MX$140.7B | MX$1,790.84 | 0.19% down | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | MX$90.4B | MX$1,605.40 | 2.16% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | MX$187.4B | MX$1,239.71 | 4.79% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | MX$445.1B | MX$388.24 | 0.64% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | MX$527.8B | MX$728.37 | 0.26% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | MX$85.6B | MX$782.14 | 1.38% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | MX$143.1B | MX$410.59 | 3.05% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | MX$749.6B | MX$1,303.75 | 0.63% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | MX$927.6B | MX$794.97 | 1.13% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | MX$594.9B | MX$964.75 | 1.58% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | MX$160.6B | MX$5,746.43 | 0.15% down | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | MX$147.3B | MX$876.84 | 2.27% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | MX$1.28T | MX$401.54 | 1.64% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | MX$6.41T | MX$2,600.90 | 3.84% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | MX$155.6B | MX$2,383.58 | 1.35% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | MX$91.4B | MX$952.68 | 1.17% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | MX$112.7B | MX$5,634.75 | 1.66% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | MX$12.41T | MX$5,154.45 | 1.96% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | MX$298.4B | MX$4,649.44 | 2.39% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | MX$1.85T | MX$17,886.36 | 1.01% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | MX$23.28T | MX$26,134.37 | 2.13% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | MX$2.31T | MX$1,128.12 | 2.53% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | MX$119.7B | MX$2,946.51 | 0.97% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | MX$113.8B | MX$1,742.83 | 0.47% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | MX$335.1B | MX$5,109.08 | 0.13% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | MX$2.57T | MX$10,139.50 | 0.61% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | MX$9.52T | MX$5,387.43 | 2.47% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | MX$5.52T | MX$2,924.62 | 2.58% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | MX$464.9B | MX$10,915.03 | 0.94% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | MX$253.4B | MX$506.90 | 3.95% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | MX$286.3B | MX$1,469.57 | 1.43% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | MX$870.3B | MX$7,618.96 | 2.27% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | MX$3.02T | MX$530.01 | 1.32% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | MX$155.3B | MX$2,240.39 | 1.84% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | MX$224.3B | MX$1,158.02 | 4.91% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | MX$115.7B | MX$818.74 | 0.95% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | MX$1.84T | MX$918.53 | 1.12% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | MX$236B | MX$283.07 | 1.45% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | MX$5.23T | MX$3,374.36 | 1.87% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | MX$108.4B | MX$159.22 | 2.20% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | MX$2.14T | MX$889.48 | 0.80% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | MX$133B | MX$2,528.93 | 1.39% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | MX$140.7B | MX$1,285.83 | 2.73% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | MX$3.28T | MX$743.75 | 3.13% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | MX$3.43T | MX$1,977.59 | 0.11% up | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | MX$94.8B | MX$1,134.35 | 0.38% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | MX$134.9B | MX$968.33 | 0.62% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | MX$91.7B | MX$527.27 | 0.36% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | MX$175.7B | MX$7,564.35 | 4.98% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | MX$138B | MX$1,576.63 | 1.80% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | MX$661.3B | MX$1,627.47 | 3.34% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | MX$159.2B | MX$199.12 | 1.08% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | MX$496.6B | MX$2,263.60 | 1.53% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | MX$59.4B | MX$305.99 | 0.68% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | MX$87.2B | MX$523.88 | 3.00% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | MX$378.1B | MX$2,823.13 | 4.38% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 18.8649 MXN).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 20:14 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of MX$95.55T as of 18 Nov 2026, 20:14 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.